SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003343
Filing Date
2020-03-04
Accepted
2020-03-04 16:06:38
Documents
77
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1905166
2 ex4-6.htm EX-4.6 32692
3 ex10-6.htm EX-10.6 11629
4 ex10-15.htm EX-10.15 27177
5 ex10-23.htm EX-10.23 42402
6 ex23-1.htm EX-23.1 6744
7 ex31-1.htm EX-31.1 15735
8 ex31-2.htm EX-31.2 15398
9 ex32-1.htm EX-32.1 7195
10 ex32-2.htm EX-32.2 7067
  Complete submission text file 0001493152-20-003343.txt   5653724

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE ogen-20191231.xml EX-101.INS 678585
12 XBRL SCHEMA FILE ogen-20191231.xsd EX-101.SCH 53338
13 XBRL CALCULATION FILE ogen-20191231_cal.xml EX-101.CAL 62242
14 XBRL DEFINITION FILE ogen-20191231_def.xml EX-101.DEF 193948
15 XBRL LABEL FILE ogen-20191231_lab.xml EX-101.LAB 370568
16 XBRL PRESENTATION FILE ogen-20191231_pre.xml EX-101.PRE 288504
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32188 | Film No.: 20687183
SIC: 2834 Pharmaceutical Preparations